Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: A case series of 12 patients

International Journal of Cardiology

Volumn 125, Issue 3, 2008, Pages 416-417

  Tay, Edgar Lik Wui ^a   Geok Mui, Michelle Koh ^a   Poh Hoon, Margaret Choong ^a   Yip, James ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Phosphodiesterase inhibitors; Pulmonary hypertension

Indexed keywords

SILDENAFIL; TADALAFIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; ECHOCARDIOGRAPHY; EXERCISE; HEMODYNAMICS; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; CARBOLINES; EXERCISE TOLERANCE; FEMALE; HALF-LIFE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SULFONES;

EID: 40949157993     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.01.046     Document Type: Article

References (7)

1. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
2. Ghofrani H.A., Wiedemann R., Rose F., et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136 (2002) 515-522
3. Sastry B.K., Narasimhan C., Reddy N.K., and Raju B.S. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 43 (2004) 1149-1153
4. Forgue S.T., Patterson B.E., Bedding A.W., et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol 61 (2006) 280-288
5. Serres F., Nicolle A.P., Tissier R., Gouni V., Pouchelon J.L., and Chetboul V. Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog. J Vet Med A Physiol Pathol Clin Med 53 (2006) 129-133
6. Palmieri E.A., Affuso F., Fazio S., and Lembo D. Tadalafil in primary pulmonary arterial hypertension. Ann Intern Med 141 (2004) 743-744
7. Ghofrani H.A., Voswinckel R., Reichenberger F., et al. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol 44 (2004) 1488-1496